THE SCHRODINGER BUILDING, OXFORD, X0
Unveils Post-Combination Technology-Enabled Portfolio with More Than 10 Clinical and Preclinical Programs, 10 Advanced Discovery Programs, and More Than 10 Partnered Programs
Shareholders Approve the Proposed Combination
The Chair
Material disclosure
Business Combination Proposed—Your Vote Is Very Important
INSTITUTIONAL SHAREHOLDER IRREVOCABLE UNDERTAKING
Annual and Transition Report of Foreign Private Issuers
Notice of Suspension of Duty to File Reports
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities to be Offered to Employees
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
Prospectus filed pursuant to Rule 424(b)(4)
No filings found
Amended Schedule 13G - Ownership Report
Amended Schedule 13D - Ownership Report
Notification Filed by a National Security Exchange
Notice of Proposed Sale of Securities
S-8 POS
Correspondence
Submission Upload
Registration Statement for Additional Securities of Certain Foreign Private Issuers, Filed Pursuant to Rule 462(b)
SEC Staff Correspondence